Leon Chen Logic Bio Therapeutics, Inc. (LOGC) insider trading activity

LOGC Quotes by TradingView

Leon Chen is Director of LogicBio Therapeutics, Inc.. Currently has a direct ownership of 0 shares of LOGC, which is worth approximately $0. The most recent transaction as insider was on Nov 16, 2022, when has been sold 22,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Leon Chen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 16 2022
SELL
Sale (or disposition) back to the issuer
-
22,333 Reduced 100.0%
0 Common Stock
Jan 01 2021
BUY
Exercise of conversion of derivative security
-
3,298 Added 50.0%
3,298 Common Stock

Also insider at

NRIX
Nurix Therapeutics, Inc. Healthcare
Director
LC

Leon Chen

Director
San Francisco, CA

Track Institutional and Insider Activities on LOGC

Follow LogicBio Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LOGC shares.

Notify only if

Insider Trading

Get notified when an Logic Bio Therapeutics, Inc. insider buys or sells LOGC shares.

Notify only if

News

Receive news related to LogicBio Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on LOGC